Fluent Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-63,638
Closed -$3.95M 61
2021
Q1
$3.95M Hold
63,638
2.07% 19
2020
Q4
$3.95M Sell
63,638
-27,527
-30% -$1.69M 2.07% 19
2020
Q3
$5.5M Sell
91,165
-432
-0.5% -$26K 3.3% 10
2020
Q2
$5.39M Buy
91,597
+6,326
+7% +$378K 3.31% 8
2020
Q1
$4.75M Buy
85,271
+14,253
+20% +$871K 3.43% 5
2019
Q4
$4.56M Buy
+71,018
New +$4.07M 2.8% 9

Other funds holding BMY

Fluent Financial's BMY Position: Q2 2021 in Review

Fluent Financial sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 63,638 shares — an estimated $3.95M sold.

Fluent Financial first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $5.5M in Q3 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Fluent Financial reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Fluent Financial sold 63,638 Bristol-Myers Squibb shares in Q2 2021, an estimated $3.95M.
  • Fluent Financial first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
  • Fluent Financial's Bristol-Myers Squibb position peaked at $5.5M in Q3 2020.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Fluent Financial's 13F filing for Q2 2021, filed 3 Aug 2021.